GeoVax Labs, Inc.
USD1.27
-0.01 (-0.78%)
CEO
David Alan Dodd
IPO Date
2020-09-25
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$1.27
Prev. Close
$1.28
Day Low
$1.24
Day High
$1.29
52W Low
$0.96
52W High
$23.10
Market Cap
$0.00B
Volume
0.13M
| 6,000 |
| $1.18 |
| 22 Jun 2026 | MCNALLY ROBERT T | director | A-Award | Acquired | 6,000 | $1.18 |
| 22 Jun 2026 | Lemerond Nicole | director | A-Award | Acquired | 6,000 | $1.18 |
| 22 Jun 2026 | Kollintzas Dean G | director | A-Award | Acquired | 6,000 | $1.18 |
| 22 Jun 2026 | CHASE RANDAL D | director | A-Award | Acquired | 6,000 | $1.18 |
| 22 Jun 2026 | Sharkey John W. | VP, Business Development | A-Award | Acquired | 17,600 | $1.18 |
| 22 Jun 2026 | Reynolds Mark | CFO | A-Award | Acquired | 17,600 | $1.18 |
| 22 Jun 2026 | NEWMAN MARK J | Chief Scientific Officer | A-Award | Acquired | 17,600 | $1.18 |
| 22 Jun 2026 | McKee Kelly T. Jr. | Chief Medical Officer | A-Award | Acquired | 17,600 | $1.18 |